Trials / Completed
CompletedNCT02809352
Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer
Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program Entitled START-HPV (STudy of Primary Screening in the ARdennes Department by Testing for HPV Infection)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 348 (actual)
- Sponsor
- CHU de Reims · Academic / Other
- Sex
- Female
- Age
- 31 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Cervical cancer is due to a persistent infection with a group of viruses known as high-risk Human Papillomaviruses (hrHPV). Viral DNA can be easily detected in a cervical sample by a procedure called 'HPV testing', which can be used as a relevant screening test. A pilot screening program called START-HPV has been set up in the Ardennes, a French administrative area localized in the North of France, with HPV testing as a primary screening test.This observational study aimed to evaluate hrHPV genotypes repartition in the population who participate in the START-HPV screening program. This study will allow a better knowledge of hrHPV infection epidemiology in a screened population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Human papillomavirus genotyping |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2014-12-01
- First posted
- 2016-06-22
- Last updated
- 2016-06-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02809352. Inclusion in this directory is not an endorsement.